
Current Price | $2.70 | Mkt Cap | $215.6M |
---|---|---|---|
Open | $2.70 | P/E Ratio | -2.54 |
Prev. Close | $2.70 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $2.65 - $2.73 | Volume | 329,003 |
52-Wk Range | $0.92 - $3.16 | Avg. Daily Vol. | 257,146 |
Current Price | $2.70 | Mkt Cap | $215.6M |
---|---|---|---|
Open | $2.70 | P/E Ratio | -2.54 |
Prev. Close | $2.70 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $2.65 - $2.73 | Volume | 329,003 |
52-Wk Range | $0.92 - $3.16 | Avg. Daily Vol. | 257,146 |
The best Bull and Bear pitches based on recency and number of recommendations.
They are creating the new wave of medical diagnostic machines. The tiny scale of their devices will increase use in space, the battlefield, 3rd world countries, scientific research and even robotics and computing. Besides increasing use it will… More
Marketing to a very select audience. Agriculture biology? Only 300 systems sold and 10 mil dollars in REVENUE each year. This company makes very little money with lots of expenses.
Read the most recent pitches from players about FLDM.
Recs
• The turnaround for this San Francisco company will likely take place in the 2. half of 2017 - with a Mkt.Cap of 200m$ & rev. of 100m$ a year in a high-margin business, there's a lot of upside potential.
• Fluidigm is maturing - financially disciplined, refocused attention on core rev. for the future & currently streamlining internal communications, team-structures & work-flow.
• Early adopters of "CyTOF" -like univ. researchers- have leveraged this technology in single cell analysis to obtain results previously not possible, & CyTOF is seeing more-&-m. positive attention & interest in the life-sciences (just google "CyTOF").
• CyTOF was first developed between the Univ. of Toronto & DVS Sciences Inc. which Fluidigm acquired in 2014 & further developed (https://en.m.wikipedia.org/wiki/Mass_cytometry).
• May 2017 conf. call (https://seekingalpha.com/article/4069444-fluidigm-corps-fldm-ceo-stephen-linthwaite-q1-2017-results-earnings-call-transcript).
• Institutional ownership is at ~100% (http://www.nasdaq.com/symbol/fldm/institutional-holdings)
... for a company this small, there is obviously significant risk & you should do your own research & only invest in what you understand... with that being said - if you were ever looking for an "early company" before they were discovered & their potential realized by the broader market (and not just their customers), then you should take a look at Fluidigm.
• Insider shares traded have also been relatively healthy
(http://www.nasdaq.com/symbol/fldm/insider-trades)
• Universities & research-institutions adopting Fluidigm's tech. are also likely to invest in the company.
• But you should only invest in something you understand - Googling "Fluidigm", "CyTOF" or "Mass Cytometry" is a good place to start...
Recs
Little understanding of the bio tools space undervalues this stock.
Recs
Dipping in my toes here, seems to be breaking out a bit, and does have some really neat technology (I have been a big fan of the CyTOF for a while). CyTOF alone is probably worth more than $1B.
Find the members with the highest scoring picks in FLDM.
4sigma (29.24) Score: +293.72
The Score Leader is the player with the highest score across all their picks in FLDM.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
4sigma | 29.24 | 2/14/2012 |
![]() |
5Y | $14.54 | -81.43% | +212.29% | +293.72 | 3 Comments | |
mountaincouger | 26.49 | 7/25/2012 |
![]() |
5Y | $12.95 | -79.15% | +213.96% | +293.11 | 0 Comment | |
Squeege1981 | 72.05 | 12/24/2012 |
![]() |
3Y | $14.44 | -81.30% | +195.89% | +277.20 | 0 Comment | |
CAPSTech | 61.56 | 11/1/2013 |
![]() |
3M | $31.39 | -91.40% | +140.11% | +231.51 | 0 Comment | |
wahodges | 78.30 | 5/19/2014 |
![]() |
5Y | $27.08 | -90.03% | +124.62% | +214.65 | 0 Comment | |
andrewdski | 76.61 | 1/20/2015 |
![]() |
3M | $36.47 | -92.60% | +109.76% | +202.35 | 0 Comment | |
Lmar | 95.95 | 8/14/2015 |
![]() |
5Y | $12.65 | -78.66% | +102.27% | +180.93 | 0 Comment | |
sikiliza | < 20 | 7/22/2019 |
![]() |
5Y | $11.49 | -76.50% | +41.66% | +118.16 | 0 Comment | |
constructive | 97.69 | 8/7/2017 |
![]() |
5Y | $3.16 | -14.56% | +70.35% | +84.90 | 0 Comment | |
NorteClub | 92.25 | 7/29/2020 |
![]() |
5Y | $5.86 | -53.92% | +30.88% | +84.80 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.